Cargando…

Surgery Treatment of Primary Tumors of the Inferior Vena Cava

BACKGROUND: Primary tumor of the inferior vena cava is a rare tumor, which arises from the smooth muscle of vascular walls. Surgery appears the only curative treatment. However, the optimal surgical methods and surgical management are not well-studied. In this article, we reviewed the successful tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shizhi, Li, Yuqiu, Yang, Qijun, Zhang, Xue, Cheng, Yunqi, Li, Zimeng, Wang, Jingyi, Zeng, Qingfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924448/
https://www.ncbi.nlm.nih.gov/pubmed/35308557
http://dx.doi.org/10.3389/fmed.2022.770967
_version_ 1784669857799733248
author Wang, Shizhi
Li, Yuqiu
Yang, Qijun
Zhang, Xue
Cheng, Yunqi
Li, Zimeng
Wang, Jingyi
Zeng, Qingfu
author_facet Wang, Shizhi
Li, Yuqiu
Yang, Qijun
Zhang, Xue
Cheng, Yunqi
Li, Zimeng
Wang, Jingyi
Zeng, Qingfu
author_sort Wang, Shizhi
collection PubMed
description BACKGROUND: Primary tumor of the inferior vena cava is a rare tumor, which arises from the smooth muscle of vascular walls. Surgery appears the only curative treatment. However, the optimal surgical methods and surgical management are not well-studied. In this article, we reviewed the successful treatment experience of patients in our center who had resection of primary tumor of the inferior vena cava and reviewed the relevant literature. METHODS: Four cases of patients who undergoing initial resection of primary tumors of the inferior vena cava from September 2017 to August 2021 in the Second Affiliated Hospital of Nanchang University were screened and followed up. They were discussed and cases reported in this field were reviewed. RESULTS: Among the four patients, three of them were female. The median age of the disease is 53.75 years (range 45–60 years). After surgical treatment, tumors were removed in all patients, and some patients had reconstruction of inferior vena cava. There were no disease-specific deaths, no serious complications, and no recurrence during follow-up in these cases. CONCLUSIONS: Careful preoperative examination, correct surgical treatment methods, and multidisciplinary collaboration can lead to safe and successful operations, which improve the survival rate of patients.
format Online
Article
Text
id pubmed-8924448
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89244482022-03-17 Surgery Treatment of Primary Tumors of the Inferior Vena Cava Wang, Shizhi Li, Yuqiu Yang, Qijun Zhang, Xue Cheng, Yunqi Li, Zimeng Wang, Jingyi Zeng, Qingfu Front Med (Lausanne) Medicine BACKGROUND: Primary tumor of the inferior vena cava is a rare tumor, which arises from the smooth muscle of vascular walls. Surgery appears the only curative treatment. However, the optimal surgical methods and surgical management are not well-studied. In this article, we reviewed the successful treatment experience of patients in our center who had resection of primary tumor of the inferior vena cava and reviewed the relevant literature. METHODS: Four cases of patients who undergoing initial resection of primary tumors of the inferior vena cava from September 2017 to August 2021 in the Second Affiliated Hospital of Nanchang University were screened and followed up. They were discussed and cases reported in this field were reviewed. RESULTS: Among the four patients, three of them were female. The median age of the disease is 53.75 years (range 45–60 years). After surgical treatment, tumors were removed in all patients, and some patients had reconstruction of inferior vena cava. There were no disease-specific deaths, no serious complications, and no recurrence during follow-up in these cases. CONCLUSIONS: Careful preoperative examination, correct surgical treatment methods, and multidisciplinary collaboration can lead to safe and successful operations, which improve the survival rate of patients. Frontiers Media S.A. 2022-03-02 /pmc/articles/PMC8924448/ /pubmed/35308557 http://dx.doi.org/10.3389/fmed.2022.770967 Text en Copyright © 2022 Wang, Li, Yang, Zhang, Cheng, Li, Wang and Zeng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Wang, Shizhi
Li, Yuqiu
Yang, Qijun
Zhang, Xue
Cheng, Yunqi
Li, Zimeng
Wang, Jingyi
Zeng, Qingfu
Surgery Treatment of Primary Tumors of the Inferior Vena Cava
title Surgery Treatment of Primary Tumors of the Inferior Vena Cava
title_full Surgery Treatment of Primary Tumors of the Inferior Vena Cava
title_fullStr Surgery Treatment of Primary Tumors of the Inferior Vena Cava
title_full_unstemmed Surgery Treatment of Primary Tumors of the Inferior Vena Cava
title_short Surgery Treatment of Primary Tumors of the Inferior Vena Cava
title_sort surgery treatment of primary tumors of the inferior vena cava
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924448/
https://www.ncbi.nlm.nih.gov/pubmed/35308557
http://dx.doi.org/10.3389/fmed.2022.770967
work_keys_str_mv AT wangshizhi surgerytreatmentofprimarytumorsoftheinferiorvenacava
AT liyuqiu surgerytreatmentofprimarytumorsoftheinferiorvenacava
AT yangqijun surgerytreatmentofprimarytumorsoftheinferiorvenacava
AT zhangxue surgerytreatmentofprimarytumorsoftheinferiorvenacava
AT chengyunqi surgerytreatmentofprimarytumorsoftheinferiorvenacava
AT lizimeng surgerytreatmentofprimarytumorsoftheinferiorvenacava
AT wangjingyi surgerytreatmentofprimarytumorsoftheinferiorvenacava
AT zengqingfu surgerytreatmentofprimarytumorsoftheinferiorvenacava